SIGMAR1 and Parkinson disease: A wide range of evidence is now available to support the role of Sig-1R in the treatment of several CNS disorders, such Parkinson disease or ischemia (Nguyen et al., 2017; Haga et al., 2019; Zhao et al., 2019).